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Poliovirus:  new insights from an old paradigm
Michelle W Wien1, Marie Chow2 and James M Hogle1,3*
A combination of structural and genetic studies of
poliovirus suggests that the final stages of viral
assembly lock the virus in a metastable structure primed
to undergo the receptor-catalyzed conformational
changes required for cell entry. Future studies promise
to provide detailed insights into the conformational
dynamics of the virion during its life cycle.
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This year marks the 40th anniversary of the introduction of
the Salk formalin-inactivated polio vaccine and the 35th
anniversary of the introduction of the Sabin live attenuated
polio vaccine. The widespread use of these vaccines has
resulted in the virtual elimination of poliomyelitis from the
western hemisphere and Europe. As a result, many of the
readers of this review have grown up in an environment in
which poliomyelitis is of minimal concern to public health.
For those who were fortunate enough to have grown up
free of the specter of yearly summer polio epidemics, two
points are worth noting. First, poliomyelitis remains
endemic in many areas, and the World Health Organiza-
tion and the Expanded Program of Immunization are in
the midst of a major campaign to eradicate poliomyelitis
worldwide by the year 2000. Second, in the twenty years
prior to the introduction of the Salk and Sabin vaccines,
poliomyelitis occupied a similar place in national con-
sciousness and the biomedical research community to that
occupied by AIDS today. As a consequence of the interna-
tional research effort to develop vaccines, poliovirus and
other members of the picornavirus family have emerged as
paradigms for our understanding of the biology of animal
viruses and their interactions with their hosts.
Simple virus, complex function
The picornaviruses are among the simplest of the animal
viruses. The virion consists of an icosahedral protein shell,
comprising sixty copies of each of four coat proteins (VP1,
VP2, VP3 and VP4). This shell encapsidates a unique
single stranded positive (message) sense RNA genome
approximately 7500 nucleotides in length. The simplicity
of the virion belies the complexity of the functions of its
components. To establish infection the virus must recog-
nize a specific receptor on the surface of susceptible cells
and be internalized. The virion (which is stable in a
variety of adverse conditions in the extracellular milieu)
must then disassemble to release the viral RNA for repli-
cation. The virion must coordinate this process of disas-
sembly with that of crossing a membrane to gain access to
the cytoplasm. After release, the RNA must be replicated
and translated. Finally, the newly replicated components
must assemble, and the resulting progeny virions escape
the cell to initiate a new round of replication. 
In the cell, the RNA genome is translated in a single open
reading frame to yield a polyprotein (~200 kDa) that is
processed by virally encoded proteases. An early cleavage
releases the capsid protein sequences from the N terminus
of the polyprotein in the form of a 100 kDa precursor (P1).
Subsequent processing of this protein, to yield VP1, VP3
and an immature capsid protein precursor VP0, is associ-
ated with the early steps in viral assembly that yield a
pentameric assembly intermediate. Two additional assem-
bly intermediates are observed in infected cells: an empty
capsid consisting of sixty copies each of VP1, VP3, and VP0
and a provirion also consisting of sixty of each of these pro-
teins but containing, in addition, the RNA genome. It is
not clear whether the viral RNA is encapsidated by penta-
mers or by the empty capsids. The maturation cleavage of
VP0 to yield VP4 and VP2 is associated with late steps in
assembly and may require encapsidation of the viral RNA.
In poliovirus, this cleavage is known to be associated with
a significant increase in the stability of the virion.
Three-dimensional structures
All known strains of poliovirus can be classified into just
three serotypes based on their reactivity with panels of
reference antisera. The high-resolution structures of the
Mahoney strain of type 1 poliovirus and the surprisingly
closely related human rhinovirus 14 were first described in
1985 [1,2]. The structures revealed that these viruses had
prominent surface protrusions at the particle fivefold and
threefold axes, a prominent protrusion near the twofold
axis and a deep circular ‘canyon’ surrounding the protru-
sion at the fivefold axis (Fig. 1). Although they share no
discernable sequence homologies, the capsid proteins
VP1, VP2 and VP3 were shown to share a common core
structure consisting of an eight-stranded antiparallel
wedge-shaped ‘jelly-roll’ (Fig. 2). This core structure pre-
viously had been seen in the capsid proteins of three
simple plant viruses, and has since been shown to be a
common feature of many (but not all) viral capsid proteins.
In contrast to their similar core structures, each of the
proteins has a unique set of loops connecting the regular
secondary structure elements of the core; each protein also
possesses a unique, rather long, N-terminal extension. In
polioviruses, the core of VP1 is also distinguished by the
presence of a lipid ligand (which we have modelled as a
sphingosine molecule; Fig. 2) in the center of its b-barrel
core. Mutational analysis has suggested that the binding 
of this ligand may be involved in regulating the stability 
of the particle [3]. In polioviruses and rhinoviruses, the
site has been demonstrated to bind a class of antiviral
drugs that stabilize the virus and prevent conformational
changes required for productive cell entry [4,5].
In the virion the cores form the closed shell of the virus
with the narrow ends of the b barrels of VP1 pointing
toward the fivefold axes and the narrow ends of the b
barrels of VP2 and VP3 alternating around the threefold
axes. The connecting loops and C termini of the capsid
proteins decorate the outer surface of the virion and have
been shown to contain the major antigenic sites of the
virus (Fig. 3). The N-terminal extensions along with VP4
(which can be thought of as the detached N-terminal
extension of VP2) form an elaborate network on the inner
surface of the protein shell; this network is essential to the
stability of the virion (Fig. 4).
From structure to function
The structure of the virion provides direct insights into a
number of the important functions of the virus. In particu-
lar, the structure is clearly relevant to understanding at
least the initial stages of the interactions of the virus with
neutralizing antibody and with the cellular receptor.
Escape mutations selected by forcing the virus to grow in
the presence of neutralizing antibodies occur predomi-
nantly in the highly exposed loops that decorate the outer
surface of the virion [1,2]. The mutations cluster in three
distinct regions of the virus, near the fivefold, threefold
and twofold axes (Fig. 3). The clustering of the mutations
identified by physical proximity agrees very closely with
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Figure 1
The structure of poliovirus. The figure has been radially depth-cued to
accentuate the surface relief [23]. The prominent surface features
include a large star-shaped plateau formed by loops at the narrow end
of the capsid protein VP1 (blue) at the fivefold axes; a prominent three-
bladed propeller formed by the narrow ends of VP2 (yellow) and VP3
(red) at the particle threefold axes; a large surface loop of VP2 near the
particle twofold axes; and a deep pentagonal canyon which separates
the star-shaped and propeller-shaped features. The figure was
prepared using Insight (Biosym/MSI).
Figure 2
Stereo representation of a protomer
containing one copy each of VP1 (blue), VP2
(yellow), VP3 (red) and VP4 (green). The b-
barrel (‘jelly-roll’) cores of the three major coat
proteins are indicated by white ribbons. The
lipid substituent in the core of VP1 (here
modeled as sphingosine) is pink. The figure
was prepared using Insight (Biosym/MSI).
clustering of mutations identified by cross-neutralization
assays. Similarly, the prominent canyon surrounding the
peak at the fivefold axes led Rossmann and colleagues [2]
to suggest that this canyon would be an attractive candi-
date for the site of receptor attachment in rhinovirus 14
and in polioviruses. For rhinovirus, this suggestion has
been verified by image reconstructions of cryoelectron
micrographs of complexes between the virus and soluble
fragment of its receptor (ICAM-1)[6].
Structural changes are required for function
The structures of the virions themselves, however, only
provide a static picture of the extracellular form of the
virion and cannot directly address structural changes that
the virions must undergo during other stages of their life
cycle. Clearly, the network formed by VP4 and the
N-terminal extensions of VP1, VP2, and VP3 requires that
significant structural rearrangements of the chain termini
must accompany proteolytic processing and assembly. Sim-
ilarly, the relatively stable delivery form of the virus must
undergo a rearrangement to release the viral genome for
translation and replication. Long before the structure of
the poliovirus virion had been solved, a variety of experi-
mental tools had shown that attachment to receptors at
physiological temperatures resulted in a striking conforma-
tional change which resulted in the release of the internal
capsid protein VP4 [7,8]. This altered form of the virion is
often referred to as the 135S particle, as it sediments at
135S as opposed to 160S for the mature virion. This confor-
mational alteration has since been shown also to result in
the externalization of the N-terminal extension of VP1 [9].
This newly exposed peptide segment, perhaps in concert
with VP4 (which is myristoylated at its N terminus [10]),
allows the altered particle to associate with artificial lipid
bilayers [9]. The 135S particle has been suggested to be an
intermediate in the cell entry process. Although recent
data shows that cold-adapted mutants are viable at 25°C
without producing detectable levels of 135S particles (see
review by Racaniello), the failure to detect the 135S parti-
cles could be explained if these particles appeared only
transiently during infection at low temperatures. Moreover,
recent data demonstrate that the 135S particle is capable of
infecting cells in a receptor-independent fashion when
supplied at sufficiently high concentration [11]. 
The receptor as a catalyst
The 135S particle can also be produced by briefly heating
the virus to 50°C in hypotonic buffers in the presence of
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Figure 4
A stereo representation of VP4 (green) and
the N-terminal extensions of VP1 (blue), VP2
(yellow) and VP3 (red) on the inner surface of
the protein shell. The cores and external loops
of VP1,VP2, and VP3 have been removed for
clarity, and the front half of the particle has
been removed to reveal the inner surface. VP4
and the N-terminal extensions form a
continuous intertwined network. The network
links subunits within the protomer, protomers
within the pentamer, and pentamers within the
capsid. This network is only completed late in
the virus assembly process, is disrupted early
in the cell entry process and is believed to be
essential to the stability of the mature virion.
The figure was prepared using Insight
(Biosym/MSI).
Figure 3
The antigenic sites of poliovirus. Residues that mutate when the virus
is forced to grow in the presence of neutralizing monoclonal antibodies
are indicated with van der Waals spheres. The figure has been radially
depth-cued. The figure was prepared using Insight (Biosym/MSI).
calcium [11,12]. Further heating of the virus results in a
more extensive conformational change and release of the
RNA, producing a particle which sediments at 80S. Under
appropriate conditions, the RNA-containing 135S particle
serves as a required precursor to the RNA-free 80S parti-
cle.  More recent studies have shown that at 37°C, VP4
and the N-terminal extension of VP1 are reversibly and
transiently exposed, suggesting that the particle ‘breathes’
at physiological temperature [13]. This observation,
together with the ability to reproduce the transition from
intact virion to the 135S particle by heating, suggests that
the native virion may represent a metastable state of the
particle which is trapped, by energy barriers, from the path
to lower energy forms of the particle (the 135S and 80S
forms; [14]). In this model, the receptor would act much
like an enzyme, using some of its energy of binding to
lower this free energy barrier and allow the viral transition
to occur at physiological temperature. This active role for
the receptor is in sharp contrast to the more passive role
proposed for receptors for several other viruses, including
foot-and-mouth disease virus and influenza virus, in which
the receptor appears to function principally to localize the
virus on the surface of the cell. For these viruses, the
productive structural alterations required for cell entry are
induced by acidification of vesicles subsequent to inter-
nalization of the virus by endocytosis. Indeed, for foot-
and-mouth disease virus, but not for poliovirus, the
receptor can be bypassed altogether by attaching virus
antibody complexes to Fc receptors on cells that are
normally non-permissive [15].
The proposed active role for the poliovirus receptor pro-
vides a particularly convincing explanation for a growing
body of mutational data showing that viral mutations
distant from the receptor-binding site can compensate for
the presence of suboptimal receptors [16–20]. Similarly,
this active role is consistent with the observation that
mutations distant from the drug-binding site can compen-
sate for the binding of antiviral drugs that interfere with
the receptor-induced conformational changes in wild-type
virus [21]. In general, these mutations significantly lower
the stability of the virion. This suggests that they act by
lowering the energy barrier of transition to the 135S parti-
cle to compensate for the lower free energy of binding of
the suboptimal receptor or the greater stability induced by
antiviral drugs that bind in the hydrophobic pocket of
VP1. As might be expected, many of these destabilizing
mutations occur at the interfaces between protein sub-
units in the virion; however, a significant number of the
mutations also occur in the VP4 and the N-terminal exten-
sion of VP1 in the network on the inside surface of the
virion. These mutations are in portions of the proteins that
are externalized during the receptor-induced transition,
and their effect may stem from their ability to destabilize
the interactions that hold these portions of the chains in
position on the inner surface of the virion. 
The virion as an intermediate
Ironically, a more complete understanding of the effect 
of these mutations has come from structural studies of the
empty capsid assembly intermediate. The structure of this
empty capsid revealed that prior to the maturation cleavage
of VP0, much of the internal network, including the entire
N-terminal extension of VP1, portions of the N-terminal
extension of VP2, and the C-terminal region of VP4, was
either disordered or adopted different conformations from
those seen in the mature virion [22]. Based on earlier obser-
vations that intermediates containing VP0 are extremely
unstable, we have proposed that the cleavage of VP0 and
the attendant rearrangements of VP4 and the N-terminal
extension of VP1 serve to lock the particle in a metastable
state which is primed for subsequent receptor-triggered
structural rearrangements [22]; this process might thus be
compared with the setting of a mouse trap. This leads to
the satisfying (though in retrospect obvious) conclusion
that the mature virion is merely a metastable intermediate
which links assembly and cell entry [14,22]. 
Is polio dead?
A number of years ago David Baltimore gave a lecture
entitled ‘Is Polio Dead?’ in which he pointed out that
poliovirus research has periodically undergone periods of
popularity and intense activity punctuated by periods of
relatively low activity. He went on to point out that with
each lull questions were raised about the productivity of
continued research in the area, and that in each case new
technologies emerged which allowed the field to advance.
As our target becomes worldwide eradication of polio-
myelitis, it is perhaps particularly appropriate to address
this question once again. From a structural standpoint, we
believe that much remains to be learned. We are on the
verge of understanding not only the structure, but also the
dynamics of the virion as it moves through its life cycle in
the host. We have developed methods for preparing large
amounts of both the 135S particle and the RNA-free 80S
particle. Low-resolution structures determined by image
reconstruction from cryoelectron micrographs should soon
be forthcoming, and there are now realistic hopes that
these could be extended to higher resolution by either
crystallographic or improved microscopic methods. More
importantly, this structural information is being devel-
oped in parallel with complementary genetic studies and
advances in cell biology relevant to our understanding of
the early events of viral infection. These concurrent
developments provide a unique opportunity to under-
stand cell entry and pathogenesis of the virus at the
molecular level.
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